# Praluent

NDC: 0024-5901
Generic name: alirocumab
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20150724

FDA application: BLA125559

## Active ingredients

- ALIROCUMAB: 75 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-5901"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-5901
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4